ADRC Affiliated Researchers

Jeffrey Guptill, M.D.

Duke University
Biomarkers
Clinical Trials

Lisa Gwyther, M.S.W

Duke University
Current research interests: Alzheimer’s disease nursing home and assisted living care, community translation of evidence-based dementia caregiver interventions, early stage Alzheimer’s programming, non-pharmacological approaches to dementia-related behavioral symptoms.

Shuo Han, Ph.D.

Duke University
The overarching goal of our lab is to understand the interplay between human gut microbiota and host aging.

Matthew Harris, Ph.D., ABPP

UNC-Chapel Hill
Neurological illness and injury, traumatic brain injury, dementia, cognition in epilepsy and epilepsy surgery.

Melissa Harris-Gersten, PhD, RN

Clinical Associate in the School of Nursing

Duke University
Clinical Trials
REC Scholar Project: Development of a Dyadic Stress Management Toolkit for Dementia Caring Dyads

Elizabeth Hauser, Ph.D.

Duke University
Genetics
My research interests are focused on developing and applying statistical methods to search for genes causing common human diseases. Recent work has been in the development of statistical methods for genetic studies and in identifying optimal study designs for genetic studies of complex traits.

Mike Hauser, Ph.D.

Duke University
Biomarkers
Genetics
Ocular genetics and age related macular degeneration.

Gerardo Heiss, Ph.D.

UNC-Chapel Hill
Research include noninvasive measures of vascular disease in populations; genetic and environmental determinants of atherosclerosis; inflammatory precursors of diabetes and heart disease; cardiovascular health of women and minority populations; mechanisms relating socio-economic status to cardiovascular health and successful aging, and applications of electronic health records in population research.

Cristine Henage, Ed.D.

UNC-Chapel Hill
Assistant Director, Carolina Geriatric Education Center & Carolina Geriatric Workforce Enhancement Program

James Pham Ho, M.D.

UNC-Chapel Hill
Cell Biology – Cellular Aging
Cell Biology – Immunology
Cell Biology – Neurodegeneration
Neuroimaging
Stroke, Intracranial Aneurysms, AVMs, Cerebrovascular Disease

Clyde Hodge, Ph.D.

UNC-Chapel Hill
Biomarkers
Our primary focus is on understanding how the positive reinforcing effects of drugs drive repetitive drug-seeking behavior and promote the transition from use to abuse.

Jaime Hughes, Ph.D., MPH, MSW

Duke University
Research focuses on the design and dissemination of effective, scalable health promotion interventions to enhance complex older adults’ functional capacity and ability to age in place.

Deborah Hummer, DNP, MSN, RN, GCNS-BC

Associate Professor

UNC Pembroke
Dementia Care
I am board certified as a Gerontological Clinical Nurse Specialist which segues nicely to my research interests of polypharmacy, and the impact of exercise on activities of daily living. I am very much interested in quality improvement in care delivery, health outcomes, and quality of life for the older adult population.

Kim G. Johnson, MD

Core Co-Leader

Duke University
Alzheimer’s Disease
Geriatric Psychiatry
Clinical Core Leader of the Duke & UNC ADRC

Thomas Kash, Ph.D.

UNC-Chapel Hill
Synaptic Transmission and Plasticity; Identification of neuronal substrates that underlie alcohol and drug abuse induced behaviors; and Determining the impact of stress on neuronal circuitry important for emotional behavior.

Shahzad Khan, Ph.D.

UNC-Chapel Hill
Alzheimer’s Disease
Neurodegeneration
Clinical Interests: Alzheimer’s disease and related dementias, Synucleinopathies, Tauopathies Research Interests: Molecular basis of neurodegeneration; Aging; Signal Transduction

Beverly Koller, Ph.D.

UNC-Chapel Hill
Mouse models for human diseases, genes that modify disease progression

Elijah Lackey, M.D.

Duke University
Biomarkers
Neurodegeneration
Neuroinflammation
Investigating the neurodegenerative aspect of progressive multiple sclerosis. Identifying biomarkers of neuroinflammation and neurodegeneration.

Eleonora Lad, Ph.D., M.D.

Duke University
Biomarkers
Clinical Trials
1) investigating the role of neuroinflammation and abnormal protein aggregates in the pathogenesis of AMD and developing relevant treatments 2) visual function testing in dry AMD with the goal of establishing functional endpoints for future clinical studies in early AMD 3) elucidating the use of novel retinal imaging biomarkers for early diagnosis of aging diseases (AMD and Alzheimer’s disease), including through the use of artificial intelligence (machine and deep learning).